VRTX vs MSFT: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

MSFT has stronger fundamentals based on our AI analysis.

VRTX
VERTEX PHARMACEUTICALS INC / MA
BUY
86%
Confidence
VS
MSFT
MICROSOFT CORP
BUY
91%
Confidence

VRTX vs MSFT Fundamental Comparison

Metric VRTX MSFT
Revenue $12.0B $158.9B
Net Income $4.0B $66.2B
Net Margin 32.9% 41.7%
ROE 21.2% 16.9%
ROA 15.4% 10.0%
Current Ratio 2.90x 1.39x
Debt/Equity 0.01x 0.10x
EPS $15.32 $8.87

Green = Better metric | Red = Weaker metric

View Full VRTX Analysis →
View Full MSFT Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

VRTX vs AAPL MSFT vs GOOGL VRTX vs AMZN MSFT vs NVDA

VRTX vs MSFT: Frequently Asked Questions

Is VRTX or MSFT a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), MSFT has stronger fundamentals. VRTX is rated BUY (86% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.

How does VRTX compare to MSFT fundamentally?

VERTEX PHARMACEUTICALS INC / MA has ROE of 21.2% vs MICROSOFT CORP's 16.9%. Net margins are 32.9% vs 41.7% respectively.

Which stock pays higher dividends, VRTX or MSFT?

VRTX has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in VRTX or MSFT for long term?

For long-term investing, consider that VRTX has BUY rating with 86% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about VRTX vs MSFT?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For VRTX vs MSFT, the AI consensus favors MSFT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.